What isn’t as big a deal as we might think? According to The New York Times this morning, the US Preventive Services Task Force’s new recommendations about prostate cancer screening. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, risk, screening, testing | 1 Comment »
We now have data from an eighth randomized clinical trial of hypofractionated radiation therapy. There are no surprises: … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: hypofractionation, outcomes, radiation | Leave a comment »
Recent media releases have provided initial information about new tests for “advanced”, BRCA mutation-associated and for “aggressive” forms of prostate cancer that need immediate intervention. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: advanced, aggressive, BRCA, risk, test | Leave a comment »
An article in Oncology Nurse Advisor notes that “Black and white men prioritize certain treatment-related factors differently when considering prostate cancer treatment options.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: decision-making, priorities, race, risk, shared, Treatment | 1 Comment »
“Don’t underestimate patients” is a new blog post on The Health Care Blog web site by George Berger, who is a regular commentator on the posts on this web site. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: "patient power", decision, making, risk, shared | 2 Comments »
A new report in the Journal of Clinical Oncology suggests that younger patients had a somewhat lower risk for biopsy-based Gleason score upgrade while on active surveillance (AS) than older patients. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: active, age, progression, risk, surveillance | 6 Comments »
